VRCA – verrica pharmaceuticals inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

VRCA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/5

08:00 am

vrca

Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026

Low Report

Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026

Report

2/23

08:13 am

vrca

Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]

Low Report

Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]

Report

2/23

08:00 am

vrca

Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

Low Report

Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

Report

2/12

08:00 am

vrca

Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer

Medium Report

Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer

Report

2/9

08:00 am

vrca

Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

Medium Report

Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical

Report

2/7

02:07 am

vrca

Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at Wall

Medium Report

Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at Wall

Report

1/17

01:11 am

vrca

Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Wall S

Medium Report

Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Wall S

Report

1/13

05:44 am

vrca

Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

Medium Report

Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/14/2025

04:05 pm

vrca

verrica pharmaceuticals inc.

BEAT Report

-5.1%

verrica pharmaceuticals inc.

Report

8/12/2025

04:01 pm

vrca

verrica pharmaceuticals inc.

BEAT Report

-3.4%

verrica pharmaceuticals inc.

Report

5/13/2025

04:05 pm

vrca

verrica pharmaceuticals inc.

BEAT Report

-2.7%

verrica pharmaceuticals inc.

Report

3/11/2025

04:05 pm

vrca

verrica pharmaceuticals inc.

BEAT Report

-7.6%

verrica pharmaceuticals inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

Date

Time

Symbol

Headline

Impact

2/17

09:39 pm

vrca

Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC

Medium Report

Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC

Report

2/2

09:09 am

vrca

Form 3/A Verrica Pharmaceuticals For: Nov 25 Filed by: BKB Growth Investments, LLC

Low Report

Form 3/A Verrica Pharmaceuticals For: Nov 25 Filed by: BKB Growth Investments, LLC

Report

1/29

07:59 pm

vrca

Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC

Low Report

Form SCHEDULE 13G/A Verrica Pharmaceuticals Filed by: Affinity Asset Advisors, LLC

Report

1/26

04:24 pm

vrca

Form 3 Verrica Pharmaceuticals For: Nov 25 Filed by: BKB Growth Investments, LLC

Low Report

Form 3 Verrica Pharmaceuticals For: Nov 25 Filed by: BKB Growth Investments, LLC

Report

12/30

08:00 am

vrca

Form 4 Verrica Pharmaceuticals For: Dec 23 Filed by: Kirby John J.

Low Report

Form 4 Verrica Pharmaceuticals For: Dec 23 Filed by: Kirby John J.

Report

12/30

07:11 am

vrca

Form SCHEDULE 13D/A Verrica Pharmaceuticals Filed by: Caligan Partners LP

Low Report

Form SCHEDULE 13D/A Verrica Pharmaceuticals Filed by: Caligan Partners LP

Report

12/30

07:08 am

vrca

Form 3 Verrica Pharmaceuticals For: Dec 26 Filed by: Caligan Partners LP

Low Report

Form 3 Verrica Pharmaceuticals For: Dec 26 Filed by: Caligan Partners LP

Report

12/30

07:06 am

vrca

Form 3 Verrica Pharmaceuticals For: Dec 26 Filed by: Frantzreb Charles

Low Report

Form 3 Verrica Pharmaceuticals For: Dec 26 Filed by: Frantzreb Charles

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.